Literature DB >> 19629357

[Plasmatic lipid profile indicators related to insulin resistance].

Ana Carolina Junqueira Vasques1, Lina Enriqueta Frandsen Paez de Lima Rosado, Gilberto Paixão Rosado, Rita de Cassia Lanes Ribeiro, Sylvia do Carmo Castro Franceschini, Silvia Eloiza Priore, Bruno Geloneze, Dirce Ribeiro de Oliveira.   

Abstract

PURPOSE: To investigate the effectiveness of biochemical indicators from the plasmatic lipid profile to identify the insulin resistance (IR), assessed by the HOMA-IR index (Homeostasis Model Assessment -Insulin Resistance).
METHODS: 138 healthy men (20-59 years) were evaluated. The lipid profile biochemical indicators analyzed were the following: triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, and TC/HDL-C and TG/HDL-C ratios. The percentile 75 was considered as the cut-off point for IR. Statistical analysis consisted of Spearman correlation coefficient, ROC curves and calculation of the areas under the curve (AUC). RESULT: The TG/HDL-C ratio showed the strongest correlation and the greatest AUC (r = 0.334 and AUC = 0.724 +/- 0.046, p < 0.001) respectively, followed by the HDL-C (r = -0.313 and AUC = 0.716 +/- 0.052, p < 0.01), the TG (r = 0.261 and AUC = 0.048 +/- 0.674, p < 0.01) and CT/HDL-C ratio (r = 0.259 and AUC = 0.655 +/- 0.05, p < 0.01). Results for TC and LDL-C showed no statistical significant (p > 0.05).
CONCLUSION: The TG/HDL-C ratio showed the greatest ability to identify IR, proved to be an alternative and easy access instrument to assess IR in clinical practice, therefore providing diseases prevention for the adult male population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629357     DOI: 10.1590/s0104-42302009000300030

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  3 in total

1.  Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner.

Authors:  Eduardo Guimarães Hourneaux de Moura; Ivan Roberto Bonotto Orso; Bruno da Costa Martins; Guilherme Sauniti Lopes; Suzana Lopes de Oliveira; Manoel dos Passos Galvão-Neto; Marcio Correa Mancini; Marco Aurélio Santo; Paulo Sakai; Almino Cardoso Ramos; Arthur Belarmino Garrido-Júnior; Alfredo Halpern; Ivan Cecconello
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

2.  Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes.

Authors:  Sayer I Al-Azzam; Asem M Alkhateeb; Karem H Alzoubi; Raya N Alzayadeen; Mera A Ababneh; Omar F Khabour
Journal:  Exp Ther Med       Date:  2013-10-15       Impact factor: 2.447

3.  Indices of body fat distribution for assessment of lipodysthrophy in people living with HIV/AIDS.

Authors:  Aline Francielle Mota Segatto; Ismael Forte Freitas; Vanessa Ribeiro Dos Santos; Kelly Cristina de Lima Ramos Pinto Alves; Dulce Aparecida Barbosa; Alexandre Martins Portelinha Filho; Henrique Luiz Monteiro
Journal:  BMC Res Notes       Date:  2012-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.